Skip to content

Clinical trials

Dermatomyositis trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatomyositis Country / region: United Kingdom Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20101
20111
20141
20151
20181
20211
20222
20235
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting4
Terminated3
Active, not recruiting2
Approved for marketing1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Northern Care Alliance NHS Foundation Trust2
Novartis Pharmaceuticals2
argenx2
Alexion Pharmaceuticals, Inc.1
Cabaletta Bio1
Corbus Pharmaceuticals Inc.1
EMD Serono Research & Development Institute, Inc.1
Eli Lilly and Company1
Idera Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatomyositis18
Myositis11
Polymyositis10
Lung Diseases, Interstitial2
Myositis, Inclusion Body2
Arthritis1
Arthritis, Rheumatoid1
Autoimmune Diseases1
Bites and Stings1
Connective Tissue Diseases1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.